XML 60 R42.htm IDEA: XBRL DOCUMENT v3.25.1
SHAREHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of stock option activity
         
Weighted average
       
   
Number of options
and RSUs
   
Exercise price
   
Remaining
contractual term
(in years)
   
Aggregate intrinsic
value
 
                         
Outstanding at January 1, 2024
   
2,493,281
   
$
0.84
     
66.70
   
$
74,862
 
Granted
   
2,528,897
     
-
     
-
     
-
 
Exercised
   
(1,386,122
)
   
0.38
     
-
     
19,135
 
Cancelled
   
(418,135
)
   
0.13
     
-
     
-
 
Outstanding at December 31, 2024
   
3,217,921
   
$
0.47
     
86.65
   
$
25,849
 
                                 
Exercisable at December 31, 2024
   
250,710
   
$
6.07
     
2.19
   
$
717
 
                                 
Vested and expected to vest at December 31, 2024
   
2,972,446
   
$
0.52
     
85.61
   
$
48,895
 
Schedule of option activity by price range
     
Outstanding
   
Exercisable
 
Range of exercise price
   
Number of options and
RSUs
   
Weighted average
remaining contractual
life (years)
   
Weighted average
exercise price
   
Number of options and
RSUs
   
Weighted average
remaining contractual
life (years)
   
Weighted average
exercise price
 
                                       
$
-
     
2,967,211
     
93.78
   
$
-
     
-
     
-
   
$
-
 
 
2.87 –– 3.38
     
27,508
     
1.22
     
3.27
     
27,508
     
1.22
     
3.27
 
 
4.25 – 5.90
     
143,359
     
1.91
     
5.39
     
143,359
     
1.91
     
5.39
 
 
6.23 – 6.56
     
67,001
     
2.99
     
6.50
     
67,001
     
2.99
     
6.50
 
$
12.02 – 21.35
     
12,842
     
3.27
     
17.34
     
12,842
     
3.27
     
17.34
 
                                                     
         
3,217,921
     
86.65
   
$
0.47
     
250,710
     
2.19
   
$
6.07
 
Schedule of stock-based compensation expense
   
Year ended December 31,
 
   
2024
   
2023
   
2022
 
                   
Cost of revenue
 
$
2,424
   
$
942
   
$
443
 
Research and development
   
5,797
     
3,559
     
2,327
 
Selling and marketing
   
9,592
     
8,345
     
5,963
 
General and administrative
   
9,399
     
5,194
     
4,583
 
                         
Total
 
$
27,212
   
$
18,040
   
$
13,316
 
Performance Based Stock Options Member  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of stock option activity
         
Weighted average
       
   
Number of
Performance based
options and RSUs
   
Exercise price
   
Remaining
contractual term
(in years)
   
Aggregate intrinsic
value
 
                         
Outstanding at January 1, 2024
   
532,028
   
$
-
     
87.53
   
$
16,424
 
Granted
   
1,234,482
     
-
     
-
     
-
 
Exercised
   
(230,991
)
   
-
     
-
     
4,222
 
Cancelled
   
(512,317
)
   
-
     
-
     
-
 
                                 
Outstanding at December 31, 2024
   
1,023,202
   
$
-
     
99.22
   
$
8,667
 
                                 
Exercisable at December 31, 2024
   
-
     
-
     
-
     
-
 
                                 
Vested and expected to vest at December 31, 2024
   
1,276,340
   
$
-
     
96.15
   
$
19,477
 
Schedule of option activity by price range
     
Outstanding
   
Exercisable
 
Range of exercise price
   
Number of
RSUs
   
Weighted average remaining contractual life (years)
   
Weighted average exercise price
   
Number
RSUs
   
Weighted average remaining contractual life (years)
   
Weighted average exercise price
 
                                       
$
-
     
1,023,202
     
99.22
   
$
-
     
-
     
-
   
$
-